Apollo Endosurgery,Inc. (NASDAQ:APEN) Files An 8-K Amendment to Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics

ME Staff 8-k
-
0

Apollo Endosurgery,Inc. (NASDAQ:APEN) Files An 8-K Amendment to Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.05 Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.

On February 16, 2017, the Board of Directors of Apollo Endosurgery, Inc. (the “Company”) adopted an Amended and Restated Code of Business Conduct and Ethics (the “Amended Code”), which applies to all officers, directors, employees and agents of the Company. The Amended Code replaced the Lpath Code of Business Conduct and Ethics adopted in March 2012 and reflects, among other matters, certain updates to conform the Amended Code to current governance best practices and the NASDAQ Global Market governance requirements.

The foregoing description of the Amended Code is qualified in its entirety by reference to the full text of the Amended Code, a copy of which is publicly available in the corporate governance section of the Company’s website at: www.apolloendo.com.


About Apollo Endosurgery, Inc. (NASDAQ:APEN)

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company’s products include ORBERA, LAP-BAND and OverStitch. The Company’s product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.

Apollo Endosurgery, Inc. (NASDAQ:APEN) Recent Trading Information

Apollo Endosurgery, Inc. (NASDAQ:APEN) closed its last trading session down -0.32 at 11.44 with 708 shares trading hands.